January 23, 2018
A New Jersey federal judge on Tuesday narrowed a whistleblower suit accusing Zydus Pharmaceutical USA Inc. of violating several False Claims Acts by inflating the price of its generic drugs, finding that claims tied to seven state laws took place before the laws were on the books.